What did @simply_tracigirl actually say?
In two weeks of self-injecting GHK-Cu, she says she can "tell a huge difference" in her fine lines, specifically that her frown line has "gotten so much better" and feels "kind of like filled in." She also credits the peptide with collagen support, anti-inflammatory effects, and tissue repair. She plugs a telehealth provider in her bio where users can work with a doctor.
To be fair, she does not claim GHK-Cu is a drug, she does not give a dose, and she repeatedly says this is education, not medical advice. That framing matters. But the leap from "I injected this for two weeks and my frown line looks better" to a mechanistic explanation of collagen signaling is a bigger jump than she makes it sound.
Does the science back this up?
Partially, yes. GHK-Cu has a legitimate research footprint, but most of it is in vitro or animal data, not human clinical trials showing visible wrinkle reduction at two weeks.
GHK (glycyl-L-histidyl-L-lysine) is a copper-binding tripeptide found naturally in human plasma. Research going back to Pickart and Margolina (2018, Cosmetics) documents its role in stimulating fibroblast activity, upregulating collagen and elastin synthesis, and modulating antioxidant enzymes like superoxide dismutase. Finkley et al. (1989, Journal of Investigative Dermatology) showed enhanced wound contraction in animal models. A small clinical trial by Leyden et al. (2009, Journal of Cosmetic Dermatology) found topical GHK-Cu formulations improved skin laxity and fine lines after 12 weeks, not two.
Two weeks is a very short window for collagen remodeling to produce visible structural change. What she may be experiencing is real, but attributing it specifically to collagen synthesis after 14 days is not well supported by the timeline in existing studies.
What did they get wrong (or right)?
She got the basic biochemistry roughly right. GHK-Cu does interact with collagen signaling pathways. It does have documented antioxidant activity. The anti-inflammatory claim is supported by data showing GHK modulates TNF-alpha and other inflammatory mediators (Pickart et al., 2012, Biomolecules). Credit where it is due.
What she got wrong, or at least oversimplified, is the two-week timeline for visible wrinkle improvement. Collagen synthesis and skin remodeling are slow processes. Fibroblast stimulation in a petri dish does not translate directly to "my frown line is filled in" inside a fortnight. There is also no robust human RCT data on injected GHK-Cu specifically for cosmetic skin outcomes. Her results could reflect placebo effect, improved hydration, or normal skin variation.
She also says "it has so many more benefits" without specifying them. That kind of vague expansionism is where peptide content tends to slide from education into hype. Viewers deserve precision, not implied miracle status.
What should you actually know?
GHK-Cu is not a fringe compound. It has real peer-reviewed research behind it, and researchers like Loren Pickart have studied it for decades. But the gap between cell culture data and clinical outcomes in humans is wide, and injectable GHK-Cu for cosmetic use has not gone through rigorous FDA-reviewed clinical trials.
Injection also carries different risk considerations than topical application. Subcutaneous or intradermal injection of any peptide, even one with a good safety profile in research settings, introduces infection risk, injection site reactions, and dosing variability that topical products do not. None of that means it is categorically unsafe, but it means informed consent requires more than a TikTok video.
Her point about working with a doctor is genuinely good advice. Compounded peptides sourced through a telehealth provider with physician oversight is a meaningfully safer path than buying research-grade peptides from unverified online vendors. That distinction matters and she deserves credit for making it.
- GHK-Cu research is real but mostly preclinical or small-scale cosmetic topical trials
- Two-week collagen remodeling claims outpace what the published timelines support
- Injectable use requires physician oversight, which she does recommend
- Compounded injectable peptides are not equivalent to FDA-approved drug products